Literature DB >> 11095044

Exploring ADHD age-of-onset criterion in Brazilian adolescents.

L A Rohde1, J Biederman, H Zimmermann, M Schmitz, S Martins, S Tramontina.   

Abstract

OBJECTIVE: To explore age-of-onset criterion for the diagnosis of attention-deficit hyperactivity disorder (ADHD) in a school sample of young Brazilian adolescents.
METHODS: 191 students aged 12 to 14 years were evaluated using DSM-IV ADHD criteria, measures of ADHD symptoms and global impairment.
RESULTS: Both adolescents with ADHD (n = 30) and adolescents who fulfilled all DSM-IV ADHD criteria, except age of onset of impairment criterion (ADHD w/o age-of-onset, n = 27) had significantly higher scores on Attention Problems, Delinquent and Aggressive Behavior scales of the Child Behavior Checklist (CBCL) and lower scores on the Child Global Assessment scale (CGAS) than non-ADHD adolescents (n = 134). Adolescents with ADHD and youths with ADHD w/o age-of-onset did not differ significantly in any measure assessed.
CONCLUSION: These results concur with recent literature proposing revision of the age-of-onset criterion for the diagnosis of ADHD.

Entities:  

Mesh:

Year:  2000        PMID: 11095044     DOI: 10.1007/s007870070045

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  10 in total

1.  Lack of gender effects on subtype outcomes in adults with attention-deficit/hyperactivity disorder: support for the validity of subtypes.

Authors:  Eugenio H Grevet; Claiton H D Bau; Carlos A I Salgado; Aline G Fischer; Katiane Kalil; Marcelo M Victor; Christiane R Garcia; Nyvia O Sousa; Luis A Rohde; Paulo Belmonte-de-Abreu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-05-12       Impact factor: 5.270

2.  ADHD and risk for subsequent adverse childhood experiences: understanding the cycle of adversity.

Authors:  Claudia Lugo-Candelas; Thomas Corbeil; Melanie Wall; Jonathan Posner; Hector Bird; Glorisa Canino; Prudence W Fisher; Shakira F Suglia; Cristiane S Duarte
Journal:  J Child Psychol Psychiatry       Date:  2020-12-02       Impact factor: 8.982

3.  Parental recall of pre-school behavior related to ADHD and disruptive behavior disorder.

Authors:  Eyüp Sabri Ercan; Oya Somer; Sonia Amado; Dennis Thompson
Journal:  Child Psychiatry Hum Dev       Date:  2005

4.  Attention deficit and hyperactivity disorder among school children in Kinshasa, Democratic Republic of Congo.

Authors:  E Kashala; T Tylleskar; I Elgen; K T Kayembe; K Sommerfelt
Journal:  Afr Health Sci       Date:  2005-09       Impact factor: 0.927

Review 5.  Attention-deficit/hyperactivity disorder: a neuropsychological perspective towards DSM-V.

Authors:  Gerry A Stefanatos; Ida Sue Baron
Journal:  Neuropsychol Rev       Date:  2007-03       Impact factor: 7.444

6.  Personality traits among ADHD adults: implications of late-onset and subthreshold diagnoses.

Authors:  S V Faraone; A Kunwar; J Adamson; J Biederman
Journal:  Psychol Med       Date:  2008-06-30       Impact factor: 7.723

7.  Diagnosing and treating attention-deficit/hyperactivity disorder in adults.

Authors:  Stephen V Faraone; Kevin M Antshel
Journal:  World Psychiatry       Date:  2008-10       Impact factor: 49.548

8.  Exploration of ADHD Subtype Definitions and Co-Occurring Psychopathology in a Missouri Population-Based Large Sibship Sample.

Authors:  Angela M Reiersen; Alexandre A Todorov
Journal:  Scand J Child Adolesc Psychiatr Psychol       Date:  2013-03

9.  Sex and age differences in attention-deficit/hyperactivity disorder symptoms and diagnoses: implications for DSM-V and ICD-11.

Authors:  Ujjwal P Ramtekkar; Angela M Reiersen; Alexandre A Todorov; Richard D Todd
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-03       Impact factor: 8.829

10.  A review of changes to the attention deficit/hyperactivity disorder age of onset criterion using the checklist for modifying disease definitions.

Authors:  Sharon Sanders; Rae Thomas; Paul Glasziou; Jenny Doust
Journal:  BMC Psychiatry       Date:  2019-11-12       Impact factor: 3.630

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.